Kinney Horn - Mar 10, 2022 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
CHIEF BUSINESS OFFICER
Signature
/s/ John B. Moriarty, Jr., Attorney-in-Fact
Stock symbol
OLMA
Transactions as of
Mar 10, 2022
Transactions value $
-$14,110
Form type
4
Date filed
3/14/2022, 04:45 PM
Previous filing
Feb 14, 2022
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Options Exercise $10.8K +5.25K +213.71% $2.06* 7.71K Mar 10, 2022 Direct
transaction OLMA Common Stock Sale -$25K -5.25K -68.12% $4.75 2.46K Mar 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OLMA Stock Option (Right to Buy) Options Exercise $0 -5.25K -3.57% $0.00 142K Mar 10, 2022 Common Stock 5.25K $2.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
F2 The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.